- Home
- FATE vs NCTY Comparison
FATE vs NCTY Comparison
Compare FATE & NCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- NCTY
- Stock Information
- Founded
- FATE 2007
- NCTY 1999
- Country
- FATE United States
- NCTY China
- Employees
- FATE N/A
- NCTY N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- NCTY Business Services
- Sector
- FATE Health Care
- NCTY Consumer Discretionary
- Exchange
- FATE Nasdaq
- NCTY Nasdaq
- Market Cap
- FATE 177.7M
- NCTY 156.7M
- IPO Year
- FATE 2013
- NCTY 2004
- Fundamental
- Price
- FATE $1.14
- NCTY $9.79
- Analyst Decision
- FATE Hold
- NCTY
- Analyst Count
- FATE 7
- NCTY 0
- Target Price
- FATE $3.83
- NCTY N/A
- AVG Volume (30 Days)
- FATE 1.7M
- NCTY 69.9K
- Earning Date
- FATE 08-12-2025
- NCTY 01-01-0001
- Dividend Yield
- FATE N/A
- NCTY N/A
- EPS Growth
- FATE N/A
- NCTY N/A
- EPS
- FATE N/A
- NCTY N/A
- Revenue
- FATE $13,335,000.00
- NCTY $15,305,175.00
- Revenue This Year
- FATE N/A
- NCTY N/A
- Revenue Next Year
- FATE N/A
- NCTY N/A
- P/E Ratio
- FATE N/A
- NCTY N/A
- Revenue Growth
- FATE 105.85
- NCTY N/A
- 52 Week Low
- FATE $0.66
- NCTY $5.75
- 52 Week High
- FATE $5.92
- NCTY $20.59
- Technical
- Relative Strength Index (RSI)
- FATE 46.69
- NCTY 58.77
- Support Level
- FATE $1.05
- NCTY $7.21
- Resistance Level
- FATE $1.18
- NCTY $9.80
- Average True Range (ATR)
- FATE 0.08
- NCTY 0.52
- MACD
- FATE -0.00
- NCTY 0.33
- Stochastic Oscillator
- FATE 54.76
- NCTY 99.23
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.